Recurrence of anti-glomerular membrane antibody glomerulonephritis seems to be an unusual clinical phenomenon. Wereport a 57-year-old man with recurrence of anti-glomerular basement membraneantibody glomerulonephritis. He developed a rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody (anti-GBM Ab), and recovered with a combined treatment of prednisolone, anticoagulant and antiplatelet agents. After a 2-year remission, hematuria and proteinuria followed by renal functional deterioration occurred without any obvious cause. The second renal biopsy revealed cellular crescents with linear IgG deposition along GBM,a finding similar to the first one. The aforementioned combined treatment resulted in a gradual recovery from proteinuria and renal functional derangement.
In most patients with crescentic anti-GBMAb glomerulonephritis, renal function rapidly deteriorates. Wuet al have reported that five of 40 patients with anti-GBM Ab glomerulonephritis showed a significant improvement in renal function (1) . Twoof these patients relapsed into anti-GBM Ab glomerulonephritis. To our knowledge, five cases with recurrent anti-GBM Ab glomerulonephritis have been reported, and three of them finally succumbed to renal failure (1) (2) (3) (4) . In most relapse cases, the recurrence was associated with infection. In this report, wedescribe a case with anti-GBMAb glomerulonephritis whorelapsed without an obvious cause after a 2-year remission and recovered by ad- Anti GBM Ab (+) (+) Thereafter, the prednisolone dosage was tapered off and eventually discontinued in June, 1986. He did well during the following sixteen months with 2.1 mg/dl of serum creatinine and normal urinalysis.
In October 1987, hematuria and proteinuria occurred again-without any obvious cause. Urinary protein excretion gradually increased to 2.5 g/day and serum creatinine to 3.1 mg/dl. The patient was readmitted to our hospital in June 1988. A second renal biopsy revealed global sclerosis in 80% of 60 glomeruli and cellular crescents in others (Fig. 4) . Onelectron microscopic observation, thinning and splitting of the GBMwere observed, but there were no dense deposits. Immunofluorescent staining disclosed diffuse linear IgG and C3 depositions along the GBM,a finding similar to that in the first biopsy, although the depositions of IgG were fewer than those observed in the first biopsy specimens. (1) (2) (3) (4) . In 4 of these patients, recurrence was associated with intercurrent infection; their prognosis was poor, and 4 of 6 patients rapidly progressed to renal failure.
In our patient, neither suspected infection nor obvious abnormality was found at the recurrence time.
In our patient, it can not be completely excluded that re-exacerbation of renal damagewas ascribed to the superimposition of other renal disease or to the non-immunological progression of glomerulo- It remains unclear as to why anti-GBMAb was not detected on the second admission. A significant increase in the anti-GBMAb titer may not be always Anti-GBMAntibody Glomerulonephritis essential to the recurrence of anti-GBM Ab glomerulonephritis. Indeed, Rees et al found an increase in the serum anti-GBM Ab titer in only one of 16 relapses of Goodpasture's syndrome (7) . The activity of the disease in our patient might not have been high enough to induce an increase in the serum anti-GBM Ab titer. In summary,we reported a case of recurrent anti-GBM Ab glomerulonephritis after a two-year remission. Repeated renal biopsies revealed crescentic glomerulonephritis with linear IgG deposition along the GBM.Serum anti-GBM Ab was detected at onset but not at recurrence. Our patient achieved substantial recovery of renal function by a combined treatment with prednisolone, anticoagulant and antiplatelet agents.
